Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 161   

Articles published

MRK 58.13 +0.02 (0.03%)
price chart
Merck & Co. Inc.: I'm Long, But It Screams Overvalued Today (MRK)
... I wrote that article at the beginning of 2014 I felt KO was undervalued, purchased it and am now sitting on a nice 8.2% return, excluding dividends, in just over half a year.
Merck & Co., Inc. (MRK) Declares Quarterly Dividend of $0.44  WKRB News
Merck Announces Fourth-Quarter 2014 Dividend  The Wall Street Transcript
Related articles »  
Company Update: Merck & Co Inc (NYSE:MRK) � Merck Initiates Phase 3 Study ...
Merck & Co Inc (NYSE:MRK) [Business Wire] - Merck , known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir , an investigational antiviral agent.
Related articles »  
Interesting August Stock Options for Merck
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co Merck & Co., Inc (NYSE: MRK). So this week we highlight one interesting put contract, and one interesting call contract ...
Related articles »  
Investors Watch List � Pfizer Inc. (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK ...
Shares of Pfizer Inc. (NYSE:PFE) have received a consensus rating of �Buy� from the seventeen ratings firms that are covering the company, Stock Ratings Network reports. Six analysts have rated the stock with a hold recommendation and nine have ...
Related articles »  
Stocks to Watch � Pfizer (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK), Apollo ...
Pfizer Inc. (NYSE:PFE) has been reiterated by TheStreet Ratings as a buy with a ratings score of B+. According to TheStreet Ratings team: The company's strengths can be seen in multiple areas, such as its largely solid financial position with ...
Whats Hot Today � Pfizer (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK ...
Plaintiffs lawyers who battled Pfizer Inc. (NYSE:PFE) for more than a decade over women's cancers linked to the company's Prempro menopause drug settled a dispute over $62 million in fees, according to court papers. Pfizer Inc. (NYSE:PFE) belongs to ...
Big Movers � Pfizer Inc. (NYSE:PFE), Merck (NYSE:MRK), First Bancorp (NYSE ...  Crazy Joys
Related articles »  
Should Dividend Investors Eject Merck & Co., Inc?
Merck (NYSE: MRK ) has one of the largest dividends in health care, but does that make it one of the sector's top dividend stocks?
Related articles »  
Best Stocks - Merck & Co. Inc. (NYSE:MRK), Celgene Corporation (NASDAQ ...
Merck & Co. Inc. (NYSE:MRK) declared a quarterly dividend on Wednesday, July 23rd, American Banking & Market News reports.
Moving Stocks � Merck & Co. Inc. (NYSE:MRK), Celgene Corporation (NASDAQ ...
Merck & Co. Inc. (NYSE:MRK) known as MSD outside the United States and Canada, announced that Maria Davis - a music industry promoter and HIV advocate - and Positive Women's Network - USA (PWN-USA) - are joining its national HIV education ...
Potentials at Drug Manufacture- Merck & Co., Inc. (NYSE:MRK), Eli Lilly and Co ...
Merck & Co., Inc. (NYSE:MRK) [Trend Analysis] after opening at $57.92 hit its intraday high price of $58.34 moreover then finished at $58.34 by shares raised 1.28%.
Drug Most Active Stocks: AbbVie (NYSE:ABBV), Pfizer Inc. (NYSE:PFE), JNJ ...  Crazy Joys
Related articles »